Reuters Events | Pharma

Thought leadership and innovation for the Pharmaceutical Industry

As cost pressures continue to rise and the decision-making power shifts from physicians to a broader range of stakeholders, leading pharma companies are actively switching to key account management to develop lasting value partnerships with the evolving customer base.

Download eyeforpharma’s new whitepaper featuring first-hand insights from Key Account Managers at Daiichi Sankyo, Lilly USA, Pfizer, Eisai, Alcon and Shire.

Find out more about:

- New models of engagement
- The true meaning of the KAM role
- Organizational and structural implications